Related Experiment Video
Updated: Aug 11, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Second primary cancers in thyroid cancer patients: a multinational record linkage study
Thekkepat C Sandeep1, Mark W J Strachan, Rebecca M Reynolds
1Metabolic Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom.
The Journal of Clinical Endocrinology and Metabolism
|February 16, 2006
Summary
Patients with thyroid cancer face a 30% increased risk of developing a second primary cancer. Thyroid cancer also appears more frequently after other initial cancers, suggesting shared risk factors or treatment effects.
Area of Science:
- Oncology
- Epidemiology
Background:
- Rising thyroid cancer incidence and improved survival rates necessitate understanding secondary cancer risks.
- Thyroid cancer can occur as a second primary neoplasm following other cancer diagnoses.
Purpose of the Study:
- To evaluate the risk of developing a second primary cancer subsequent to a thyroid cancer diagnosis.
- To assess the risk of thyroid cancer as a second primary neoplasm following other initial cancers.
Main Methods:
- A multinational record linkage study involving 13 population-based cancer registries.
- Follow-up of 39,002 individuals with primary thyroid cancer for up to 25 years to identify second primary neoplasms (SPNs).
- Calculation of standardized incidence ratios (SIRs) by comparing observed SPN counts with expected numbers based on age-, sex-, and calendar period-specific incidence rates.
Main Results:
- A 30% increased risk (SIR 1.31) of any second primary cancer was observed after initial thyroid cancer.
- Significantly elevated risks were noted for numerous specific cancers following thyroid cancer.
- Increased risks of second primary thyroid cancer were also identified after various other primary cancer types.
Conclusions:
- Pooled data indicate a notable increase in second primary cancer risk after thyroid cancer and vice versa.
- While biases and chance may play a role, shared risk factors and treatment effects are likely implicated.
- Clinicians should maintain a high index of suspicion for second primary cancers in patients treated for thyroid cancer.
